An innovative therapy at a Vancouver hospital has proved highly successful in reducing surgical site infections (SSIs), local health authorities say. Vancouver General Hospital (VGH) is the first hospital in North America to use the new therapy, which has reduced SSIs cases by about 40 percent each year, according to Vancouver Coastal Health (VCH), a regional health authority in the Canadian province of British Columbia. Compared with traditional pre-surgical pharmaceutical therapies, the new therapy, called photodisinfection technology, developed by a Vancouver-based company, is a novel, non-antibiotic method that kills potentially harmful bacteria harbored in a patient's nasal passages with non-thermal light energy, VCH said earlier this week. The non-drug therapy trial at the hospital combined photodisinfection with chlorhexidine body wipes prior to surgery to decrease a patient's bacterial load on their skin and in their nostrils to reduce the risk of SSIs. More than 5,000 patients were treated with this combination therapy, and actual occurrences of SSIs dropped from an average 85 cases to 50 cases. In addition, the cases of readmission due to SSI also dropped, from four to 1.25 cases each month. The lower SSI occurrence rate would benefit patients and reduce their morbidity, said Dr. Elizabeth Bryce, Regional Medical Director of VCH's Infection Control Unit.
GMT 18:35 2018 Thursday ,11 January
Syrian refugee sets himself ablaze at UN office in LebanonGMT 18:48 2018 Tuesday ,09 January
Novo Nordisk woos Belgian nano-drug makerGMT 17:54 2017 Wednesday ,27 December
Medical evacuations begin from besieged Syria rebel bastionGMT 12:14 2017 Monday ,25 December
MoHAP successfully conducts cochlear implant operationGMT 18:24 2017 Sunday ,24 December
Palestinian conjoined twins arrive in RiyadhGMT 19:05 2017 Monday ,18 December
new! magazine names fitness & food editorGMT 17:03 2017 Wednesday ,29 November
Spain reports case of 'mad cow disease'GMT 14:05 2017 Saturday ,11 November
EU can't agree on new licence for controversial glyphosate weedkiller
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor